From: Surgical treatment on infective endocarditis: impact of diabetes on mortality
Group I (Not-DM patients) | Group II (DM patients) | p Value | |
---|---|---|---|
N | 326 | 94 | |
Age (years) | 54.8 ± 16.1 | 66.4 ± 11.1 | 0.000 |
Male gender (n, %) | 214 (65.6%) | 61 (64.9%) | 0.902 |
NIHA III-IV (n, %) | 103 (31.6%) | 37 (39.4%) | 0.234 |
Previous cardiac surgery (n, %) | 124 (38.0%) | 36 (38.3%) | 1.000 |
Native valve endocarditis (n, %) | 212 (65.0%) | 62 (66.0%) | 0.903 |
EF (%) | 54.6 ± 15.1 | 54.8 ± 15.9 | 0.914 |
Hypertension (n, %) | 136 (42.0%) | 76 (81.7%) | 0.000 |
COPD (n, %) | 15 (4.6%) | 10 (10.8%) | 0.044 |
Dialysis (n, %) | 6 (2.1%) | 5 (6.5%) | 0.057 |
Hyperlipidemia (n, %) | 100 (31.0%) | 77 (81.9%) | 0.000 |
PVD (n, %) | 7 (2.2%) | 12 (13.5%) | 0.000 |
CVA/TIA (n, %) | 46 (14.7%) | 17 (18.5%) | 0.414 |
Pulmonary hypertension (n, %) | 40 (12.9%) | 13(14.6%) | 0.723 |
Smoking (n, %) | 81 (25.3%) | 35 (38.5%) | 0.017 |
Standard EuroSCORE I | 7.4 ± 3.9 | 10.0 ± 4.1 | 0.000 |
Logistic EuroSCORE % | 16.3 ± 17.7 | 27.3 ± 24.4 | 0.000 |
Bypass time (min) | 121.7 ± 56.1 | 148.8 ± 68.1 | 0.001 |
Cross-clamp (min) | 86.1 ± 37.6 | 108.5 ± 48.3 | 0.000 |
Aortic valve involvement (n, %) | 172 (52.8%) | 55 (58.5%) | 0.349 |
Mitral valve involvement (n, %) | 175 (53.7%) | 54 (57.4%) | 0.558 |
Tricuspid valve involvement (n, %) | 2 (0.6%) | 0 (0%) | 0.280 |
Annular reconstruction (n, %) | 44 (13.5%) | 21 (22.3%) | 0.023 |
Concomitant procedure (n, %) | 128 (39.3%) | 54 (57.4%) | 0.434 |